Windtree Therapeutics is a biotechnology company focused on developing novel therapeutics for respiratory diseases. The company's lead product candidate is AEROSURF®, a drug-device combination product designed to improve the treatment of premature infants with respiratory distress syndrome. Windtree is dedicated to advancing innovative solutions to improve patient outcomes in respiratory care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#5 in Warrington, PA

#1,625 in Pennsylvania

#45,030 in US

Warrington, PA, United States of America

Windtree Therapeutics, Inc.

Forward Citations = 8

11 inventors:

Giuseppe Bianchi (3 out of 58 patents)

Patrizia Ferrari (3 out of 31 patents)

Mara Ferrandi (3 out of 14 patents)

4. Paolo Barassi (3 out of 5 patents)

5. Jan Mazela (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Windtree Therapeutics, Inc.. Retrieved from https://idiyas.com/company/windtree-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]